170 related articles for article (PubMed ID: 3258602)
1. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.
Haertle T; Carrera CJ; Wasson DB; Sowers LC; Richman DD; Carson DA
J Biol Chem; 1988 Apr; 263(12):5870-5. PubMed ID: 3258602
[TBL] [Abstract][Full Text] [Related]
2. Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes.
Carson DA; Haertle T; Wasson DB; Richman DD
Biochem Biophys Res Commun; 1988 Mar; 151(2):788-93. PubMed ID: 3258154
[TBL] [Abstract][Full Text] [Related]
3. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Richman DD; Kornbluth RS; Carson DA
J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
[TBL] [Abstract][Full Text] [Related]
4. 2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
Johnson MA; Johns DG; Fridland A
Biochem Biophys Res Commun; 1987 Nov; 148(3):1252-8. PubMed ID: 2825680
[TBL] [Abstract][Full Text] [Related]
5. Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.
Johnson MA; Ahluwalia G; Connelly MC; Cooney DA; Broder S; Johns DG; Fridland A
J Biol Chem; 1988 Oct; 263(30):15354-7. PubMed ID: 3262616
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
Balzarini J; Baba M; Pauwels R; Herdewijn P; Wood SG; Robins MJ; de Clercq E
Mol Pharmacol; 1988 Mar; 33(3):243-9. PubMed ID: 3258404
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
Kierdaszuk B; Bohman C; Ullman B; Eriksson S
Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
[TBL] [Abstract][Full Text] [Related]
8. Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside.
Pauwels R; Baba M; Balzarini J; Herdewijn P; Desmyter J; Robins MJ; Zou RM; Madej D; De Clercq E
Biochem Pharmacol; 1988 Apr; 37(7):1317-25. PubMed ID: 3258516
[TBL] [Abstract][Full Text] [Related]
9. The 2',3'-dideoxyriboside of 2,6-diaminopurine and its 2',3'-didehydro derivative inhibit the deamination of 2',3'-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication.
Balzarini J; Robins MJ; Zou RM; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 May; 145(1):277-83. PubMed ID: 3496090
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of the 2-chloro analogues of 3'-deoxyadenosine, 2',3'-dideoxyadenosine, and 2',3'-didehydro-2',3'-dideoxyadenosine as potential antiviral agents.
Rosowsky A; Solan VC; Sodroski JG; Ruprecht RM
J Med Chem; 1989 May; 32(5):1135-40. PubMed ID: 2785212
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Broder S
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
Marongiu ME; Pani A; Tinti E; Grifantini M; Franchetti P; Cristalli G; La Colla P
New Microbiol; 1995 Oct; 18(4):359-70. PubMed ID: 8590388
[TBL] [Abstract][Full Text] [Related]
14. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
Balzarini J; Pauwels R; Baba M; Robins MJ; Zou RM; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 May; 145(1):269-76. PubMed ID: 3496089
[TBL] [Abstract][Full Text] [Related]
15. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Jarrett RF; Matsukura M; Di Marzo Veronese F; DeVico AL; Sarngadharan MG; Johns DG; Reitz MS; Broder S
Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2033-7. PubMed ID: 2436223
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
Siaw MF; Coleman MS
J Biol Chem; 1984 Aug; 259(15):9426-33. PubMed ID: 6204981
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetics of new anti-HIV agents: 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Russell JW; Klunk LJ
Biochem Pharmacol; 1989 May; 38(9):1385-8. PubMed ID: 2497744
[TBL] [Abstract][Full Text] [Related]
18. Deoxyadenosine-resistant human T lymphoblasts with elevated 5'-nucleotidase activity.
Carson DA; Carrera CJ; Wasson DB; Iizasa T
Biochim Biophys Acta; 1991 Jan; 1091(1):22-8. PubMed ID: 1995064
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
Ahluwalia GS; Cooney DA; Shirasaka T; Mitsuya H; Driscoll JS; Johns DG
Mol Pharmacol; 1994 Nov; 46(5):1002-8. PubMed ID: 7969062
[TBL] [Abstract][Full Text] [Related]
20. 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.
Masood R; Ahluwalia GS; Cooney DA; Fridland A; Marquez VE; Driscoll JS; Hao Z; Mitsuya H; Perno CF; Broder S
Mol Pharmacol; 1990 Apr; 37(4):590-6. PubMed ID: 2109183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
